Global Leader In Assisted Reproductive Technology Introduces A New Physiological IVF Culture Media Suite

Main Category: Fertility
Article Date: 11 Apr 2007 - 7:00 PDT

email to a friend   printer friendly   opinions  

Cook Women's Health, a division of Cook, the world's largest private medical device manufacturer, and a global leader in assisted reproductive technology (ART), today announces the launch of a new formulation of its acclaimed physiological IVF culture media. Alterations to its Fertilisation, Cleavage and Blastocyst media suite are designed to assist the natural development of the embryo at each developmental stage, thereby maximising embryo viability and offering IVF clinics the opportunity to implement single embryo transfer.

The revised formulation includes an alteration to the constituents of its current Fertilisation, Cleavage and Blastocyst media, particularly in relation to the concentration of glucose, albumin, amino acids and added vitamins. This assists the three stages of oocyte fertilisation, embryo division and subsequent embryo development, providing the appropriate nutrients to match the gamete's and embryo's shifting metabolic requirements.

Changes to the original IVF culture media suite are the result of more than two years of extensive research working with physicians and scientists from Sydney IVF, world leaders in assisted reproductive medicine and elective single embryo transfer.

Cook believes the new media suite will provide the optimum environment for the fertilisation of the oocyte, the subsequent division of the resulting embryo and ensure optimum blastocyst development for extended culture.

The new formulation changes include:

-- An alteration of Albumin concentration in some media codes
-- An alteration of essential amino acid concentrations in Blastocyst and Cleavage Medium
-- Addition of Vitamin B5
-- Sperm Buffer and Oocyte wash buffer combined to create a single Gamete Buffer.

The complete suite has also undergone minor modifications to its packaging for product identification.

Christina Anné, Head of Cook Women's Health Global Business Unit, describes the impact of the revised culture media suite: "Cook's IVF culture media suite offers IVF clinics the opportunity to implement elective single embryo transfer by maximising embryo viability. This provides the retrieved egg with a more nurturing environment, supporting the viability of eggs in a woman's body during conventional in vitro fertilisation. Now available, this revised culture media suite is a continuation of Cook's process of collaborating with highly-regarded experts in IVF such as Sydney IVF to optimise technologies for in vitro fertilisation."

www.cookgroup.com

• Additional
• References
• Citations